Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Stankiewicz, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Fakih R, Matiello M, Chitnis T, Stankiewicz JM. Efficacy and safety of mycophenolate mofetil in progressive multiple sclerosis patients. J Neurol. 2018 Nov; 265(11):2688-2694. PMID: 30203314.
    Citations:    Fields:    Translation:Humans
  2. Tankou SK, Regev K, Healy BC, Tjon E, Laghi L, Cox LM, Kivisäkk P, Pierre IV, Hrishikesh L, Gandhi R, Cook S, Glanz B, Stankiewicz J, Weiner HL. A probiotic modulates the microbiome and immunity in multiple sclerosis. Ann Neurol. 2018 Jun; 83(6):1147-1161. PMID: 29679417.
    Citations:    Fields:    
  3. Tankou SK, Regev K, Healy BC, Cox LM, Tjon E, Kivisakk P, Vanande IP, Cook S, Gandhi R, Glanz B, Stankiewicz J, Weiner HL. Investigation of probiotics in multiple sclerosis. Mult Scler. 2018 01; 24(1):58-63. PMID: 29307299.
    Citations: 3     Fields:    
  4. Zurawski J, Stankiewicz J. Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts. Am J Med. 2018 May; 131(5):464-472. PMID: 29274753.
    Citations: 2     Fields:    
  5. Baharnoori M, Gonzalez CT, Chua A, Diaz-Cruz C, Healy BC, Stankiewicz J, Weiner HL, Chitnis T. Predictors of hematological abnormalities in multiple sclerosis patients treated with fingolimod and dimethyl fumarate and impact of treatment switch on lymphocyte and leukocyte count. Mult Scler Relat Disord. 2018 Feb; 20:51-57. PMID: 29304497.
    Citations: 1     Fields:    Translation:Humans
  6. Kim G, Chu R, Yousuf F, Tauhid S, Stazzone L, Houtchens MK, Stankiewicz JM, Severson C, Kimbrough D, Quintana FJ, Chitnis T, Weiner HL, Healy BC, Bakshi R. Sample size requirements for one-year treatment effects using deep gray matter volume from 3T MRI in progressive forms of multiple sclerosis. Int J Neurosci. 2017 Nov; 127(11):971-980. PMID: 28100092.
    Citations: 3     Fields:    Translation:Humans
  7. Baharnoori M, Lyons J, Dastagir A, Koralnik I, Stankiewicz JM. Nonfatal PML in a patient with multiple sclerosis treated with dimethyl fumarate. Neurol Neuroimmunol Neuroinflamm. 2016 Oct; 3(5):e274. PMID: 27606353.
    Citations: 10     
  8. Khalid F, Tauhid S, Chua AS, Healy BC, Stankiewicz JM, Weiner HL, Bakshi R. A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis. Int J Neurosci. 2017 May; 127(5):396-403. PMID: 27143245.
    Citations: 1     Fields:    Translation:Humans
  9. Bakshi R, Neema M, Tauhid S, Healy BC, Glanz BI, Kim G, Miller J, Berkowitz JL, Bove R, Houtchens MK, Severson C, Stankiewicz JM, Stazzone L, Chitnis T, Guttmann CR, Weiner HL, Ceccarelli A. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2. Neuroreport. 2014 Oct 01; 25(14):1156-61. PMID: 25100554.
    Citations: 11     Fields:    Translation:Humans
  10. Stankiewicz JM, Neema M, Ceccarelli A. Iron and multiple sclerosis. Neurobiol Aging. 2014 Sep; 35 Suppl 2:S51-8. PMID: 24929968.
    Citations: 7     Fields:    Translation:HumansCells
  11. Stankiewicz JM, Kolb H, Karni A, Weiner HL. Role of immunosuppressive therapy for the treatment of multiple sclerosis. Neurotherapeutics. 2013 Jan; 10(1):77-88. PMID: 23271506.
    Citations: 8     Fields:    Translation:Humans
  12. Caballero N, Bhalla V, Stankiewicz JA, Welch KC. Effect of lumbar drain placement on recurrence of cerebrospinal rhinorrhea after endoscopic repair. Int Forum Allergy Rhinol. 2012 May-Jun; 2(3):222-6. PMID: 22344940.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  13. Stankiewicz JA, Lal D, Connor M, Welch K. Complications in endoscopic sinus surgery for chronic rhinosinusitis: a 25-year experience. Laryngoscope. 2011 Dec; 121(12):2684-701. PMID: 22086769.
    Citations: 12     Fields:    Translation:Humans
  14. Klein JP, Arora A, Neema M, Healy BC, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Stankiewicz JM, Cohen AB, Buckle GJ, Houtchens MK, Ceccarelli A, Dell'Oglio E, Guttmann CR, Alsop DC, Hackney DB, Bakshi R. A 3T MR imaging investigation of the topography of whole spinal cord atrophy in multiple sclerosis. AJNR Am J Neuroradiol. 2011 Jun-Jul; 32(6):1138-42. PMID: 21527570.
    Citations: 11     Fields:    Translation:Humans
  15. Stankiewicz JM, Glanz BI, Healy BC, Arora A, Neema M, Benedict RH, Guss ZD, Tauhid S, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CR, Bakshi R. Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis. J Neuroimaging. 2011 Apr; 21(2):e50-6. PMID: 19888926.
    Citations: 32     Fields:    Translation:Humans
  16. Cohen AB, Neema M, Arora A, Dell'oglio E, Benedict RH, Tauhid S, Goldberg-Zimring D, Chavarro-Nieto C, Ceccarelli A, Klein JP, Stankiewicz JM, Houtchens MK, Buckle GJ, Alsop DC, Guttmann CR, Bakshi R. The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2012 Apr; 22(2):122-8. PMID: 21447024.
    Citations: 28     Fields:    Translation:HumansCells
  17. Healy BC, Glanz BI, Stankiewicz J, Buckle G, Weiner H, Chitnis T. A method for evaluating treatment switching criteria in multiple sclerosis. Mult Scler. 2010 Dec; 16(12):1483-9. PMID: 20736245.
    Citations: 4     Fields:    Translation:Humans
  18. Gauthier SA, Glanz BI, Mandel M, Tsagkaropoulos A, Neema M, Stankiewicz J, Arora A, Duan Y, Liptak Z, Egorova S, Buckle GJ, Bakshi R, Guttmann CR, Khoury SJ, Weiner HL. Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study. J Neurol Sci. 2009 Sep 15; 284(1-2):116-9. PMID: 19428028.
    Citations: 5     Fields:    Translation:Humans
  19. Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CR, Hackney D, Bakshi R. Spinal cord lesions and clinical status in multiple sclerosis: A 1.5 T and 3 T MRI study. J Neurol Sci. 2009 Apr 15; 279(1-2):99-105. PMID: 19178916.
    Citations: 24     Fields:    Translation:Humans
  20. Neema M, Guss ZD, Stankiewicz JM, Arora A, Healy BC, Bakshi R. Normal findings on brain fluid-attenuated inversion recovery MR images at 3T. AJNR Am J Neuroradiol. 2009 May; 30(5):911-6. PMID: 19369605.
    Citations: 15     Fields:    Translation:Humans
  21. Stankiewicz JM, Glanz B, Healy BC, Benedict RHB, Arora A, Neema M, Guss ZD, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CRG, Bakshi R. . Brain MRI lesion volume correlates with physical disability and cognitive impairment in multiple sclerosis: comparison of 1.5T and 3T. (manuscript under revision. 2009.
  22. Stankiewicz JM, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CRG, Hackney D, Bakshi R. Spinal cord lesions and clinical status in multiple sclerosis: a 1.5T and 3T MRI study. Manscript under revision. 2009.
  23. Stankiewicz JM, Brass SD. Role of iron in neurotoxicity: a cause for concern in the elderly? Curr Opin Clin Nutr Metab Care. 2009 Jan; 12(1):22-9. PMID: 19057183.
    Citations: 25     Fields:    Translation:Humans
  24. Gauthier S, Glanz B, Mandel M, Tsagkaropoulos A, Neema M, Stankiewicz J, Arora A, Duan Y, Zsuzsanna L, Egorova S, Buckle G, Bakshi R, Guttman C, Khoury S, Weiner H. . The incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study. Manuscript under revision. 2009.
  25. Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, Bakshi R. . Neuroimaging of toxic-metabolic disorders. Seminars in Neurology (in press). 2009.
  26. Bakshi R, Neema M, Healy B, Liptak Z, Betensky R, Buckle G, Gauthier S, Stankiewicz J, Meier D, Egorova S, Arora A, Guss Z, Glanz B, Khoury S, Guttmann C, Weiner H. MRI scale predicts clinical progression in MS. Archives of Neurology (in press). 2009.
  27. Bakshi R, Neema M, Healy BC, Liptak Z, Betensky RA, Buckle GJ, Gauthier SA, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury SJ, Guttmann CR, Weiner HL. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Arch Neurol. 2008 Nov; 65(11):1449-53. PMID: 19001162.
    Citations: 16     Fields:    Translation:Humans
  28. Arora A, Neema M, Stankiewicz J, Guss ZD, Guss JG, Prockop L, Bakshi R. Neuroimaging of toxic and metabolic disorders. Semin Neurol. 2008 Sep; 28(4):495-510. PMID: 18843577.
    Citations: 3     Fields:    Translation:Humans
  29. Stankiewicz J, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CRG, Hackney DB, Bakshi R. . Whole spinal cord lesion detection with 1.5T and 3T MRI and clinical correlation in multiple sclerosis. Annual Meeting of the American Academy of Neurology. 2008.
  30. Guss ZD, Stankiewicz J, Neema M, Arora A, Bakshi R. Brain nhyperintensities detected in normal volunteers on FLAIR MRI using both 1.5T and 3T. European Commitee for Treatment and Research in Multiple Sclerosis (ECTRIMS)(accepted) . 2008.
  31. Stankiewicz J, Neema M, Alsop DC, Healy BC, Arora A, Buckle GJ, Chitnis T, Guttmann CRG, Hackney DB, Bakshi R. . Whole spinal cord lesion detection with 1.5T and 3T MRI and clinical correlation in multiple sclerosis. European Commitee for Treatment and Research in Multiple Sclerosis (ECTIMS)(accepted). 2008.
  32. Guss ZD, Stankiewicz J, Neema M, Arora A, Bakshi R. . Brain hyperintensities detected in normal volunteers on FLAIR MRI using both 1.5T and 3T. Regional and whole spinal cord atrophy in multiple sclerosis. Annual Meeting of the American Academy of Neurology. 2008.
  33. Glanz B, Stankiewicz J, Healy BC, Benedict RHB, Arora A, Neema M, Guss ZD, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CRG, Bakshi R. . Brain MRI lesion volume correlates with physical disability and cognitive impairment in patients with multiple sclerosis: a comparison of 1.5T and 3T. European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)(accepted). 2008.
  34. Stankiewicz J, Glanz B, Healy BC, Benedict RHB, Arora A, Neema M, Guss ZD, Buckle GJ, Houtchens MK, Khoury SJ, Weiner HL, Guttmann CRG, Bakshi R. . Brain MRI lesion volume correlates with physical disability and cognitive impairment in patients with multiple sclerosis: a comparison of 1.5T and 3T. Annual Meeting of the American Academy of Neurology. 2008.
  35. Bakshi R, Neema M, Healy B, Liptak Z, Betensky R, Buckle G, Gauthier S, Stankiewicz J, Meier D, Egorova S, Arora A, Guss ZD, Glanz B, Khoury S, Guttmann CRG, Weiner HL. . Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis. 10th Annual Meeting of the American Society for Experimental NeuroTherapeutics. 2008.
  36. Arora A, Neema M, Stankiewicz J, Guss JG, Bakshi R. . MRI Measurement of Whole Spinal Cord Volume at 3T: Reproducibility and Relevance to Multiple Sclerosis. 10th Annual Meeting of the American Society for Experimental NeuroTherapeutics. 2008.
  37. Arora A, Neema M, Stankiewicz J, Guss JG, Bakshi R. . Regional and whole spinal cord atrophy in multiple sclerosis. Annual Meeting of the American Academy of Neurology. 2008.
  38. Neema M, Stankiewicz J, Arora A, Guss ZD, Bakshi R. MRI in multiple sclerosis: what's inside the toolbox? Neurotherapeutics. 2007 Oct; 4(4):602-17. PMID: 17920541.
    Citations: 32     Fields:    Translation:Humans
  39. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics. 2007 Jul; 4(3):371-86. PMID: 17599703.
    Citations: 64     Fields:    Translation:HumansAnimals
  40. Shirazi MA, Silver AL, Stankiewicz JA. Surgical outcomes following the endoscopic modified Lothrop procedure. Laryngoscope. 2007 May; 117(5):765-9. PMID: 17473665.
    Citations: 9     Fields:    Translation:Humans
  41. Neema M, Stankiewicz J, Arora A, Dandamudi VS, Batt CE, Guss ZD, Al-Sabbagh A, Bakshi R. T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis. J Neuroimaging. 2007 Apr; 17 Suppl 1:16S-21S. PMID: 17425729.
    Citations: 34     Fields:    Translation:Humans
  42. Neema M, Dandamudi VSR, Arora A, Stankiewicz J, Bakshi R (2007) T1 black holes and gray matter damage. In: Filippi M, Rovaris M, Comi G (eds) Neurodegeneration in Multiple Sclerosis. Springer, Milan Berlin Heidelberg New York, 37-45. ISBN: 978-88-470-0390-3. T1 black holes and gray matter damage. Neurodegeneration in Multiple Sclerosis. Filippi M, Rovaris M, Comi G (eds). 2007; 37-45.
  43. Bakshi R, Neema M, Liptak Z, Betensky R, Buckle G, Gauthier S, Stankiewicz J, Meier D, Egorova S, Arora A, Dandamudi V, Batt C, Guss Z, Glanz B, Khoury S, Guttmann C, Weiner H. . Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis. American Academy of Neurology Annual Meeting. 2007.
  44. Glass GA, Stankiewicz J, Mithoefer A, Freeman R, Bergethon PR. Levetiracetam for seizures after liver transplantation. Neurology. 2005 Mar 22; 64(6):1084-5. PMID: 15781837.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  45. Glass G, Stankiewicz J, Freeman R, Mithoefer A, Bergathon PR. . Levetiracetam in Orthotopic Liver Transplantation: Demonstrating Antiseizure efficacy and reducing dose antirejection medications in a complex patient population. American Academy of Neurology Annual Meeting. 2004.
  46. Petruzzelli GJ, Stankiewicz JA. Frontal sinus obliteration with hydroxyapatite cement. Laryngoscope. 2002 Jan; 112(1):32-6. PMID: 11802035.
    Citations: 3     Fields:    Translation:Humans
  47. Metson R, Gliklich RE, Stankiewicz JA, Kennedy DW, Duncavage JA, Hoffman SR, Ohnishi T, Terrell JE, White PS. Comparison of sinus computed tomography staging systems. Otolaryngol Head Neck Surg. 1997 Oct; 117(4):372-9. PMID: 9339799.
    Citations: 5     Fields:    Translation:Humans
  48. Shankey V, Stankiewicz J, Jin JK, Waters B, Flanigan R, Pyle J. . Genetic Instability in Histologically Normal Appearing Urothelium from Invasive Bladder Cancers. American Urological Association Annual Meeting. 1997.
  49. Shankey V, Stankiewicz J, Waters B, Flanigan R, Pyle J. . Fluorescence in-situ Hybridization Analysis of Bladder Washings as a Means to Detect Genetic Changes to the Urothelium in Transitional Cell Bladder Cancers. American Urological Association Annual Meeting. 1997.
  50. Stankiewicz JA. Complications in endoscopic intranasal ethmoidectomy: an update. Laryngoscope. 1989 Jul; 99(7 Pt 1):686-90. PMID: 2747392.
    Citations: 27     Fields:    Translation:Humans
  51. Stankiewicz JA. Complications of endoscopic intranasal ethmoidectomy. Laryngoscope. 1987 Nov; 97(11):1270-3. PMID: 3669837.
    Citations: 20     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Stankiewicz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (127)
Explore
_
Co-Authors (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.